Reversal of multidrug resistance
- 31 December 1990
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 17, 37-43
- https://doi.org/10.1016/0305-7372(90)90014-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A pilot study of quinidine and epirubicin in the treatment of advanced breast cancerBritish Journal of Cancer, 1990
- Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer a phase I/II studyCancer, 1990
- Unknotting the Complexities of Multidrug Resistance: The Involvement of DNA Topoisomerases in Drug Action and ResistanceJNCI Journal of the National Cancer Institute, 1989
- Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamilBritish Journal of Cancer, 1989
- Modulation by verapamil of vincristine pharmacokinetics and toxicity in mice bearing human tumor xenograftsBiochemical Pharmacology, 1989
- Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.Journal of Clinical Oncology, 1989
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989
- The multidrug resistance phenotypeBritish Journal of Cancer, 1988
- The effect of verapamil on the pharmacokinetics of adriamycinCancer Chemotherapy and Pharmacology, 1986
- The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humansAmerican Heart Journal, 1985